Category: chlorides-buliding-blocks

Albrecht, Dominik; Vogt, Florian; Bach, Thorsten published an article in 2010, the title of the article was Diastereo- and Enantioselective Intramolecular [2+2] Photocycloaddition Reactions of 3-(ω’-Alkenyl)- and 3-(ω’-Alkenyloxy)-Substituted 5,6-Dihydro-1H-pyridin-2-ones.Electric Literature of 14602-86-9 And the article contains the following content:

3-(ω’-Alkenyl)-substituted 5,6-dihydro-1H-pyridin-2-ones I (n = 1-3) were prepared as photocycloaddition precursors either by cross-coupling from 3-iodo-5,6-dihydro-1H-pyridin-2-one or, more favorably, from the corresponding α-(ω’-alkenyl)-substituted δ-valerolactams by a selenylation/elimination sequence (56-62% overall yield). 3-(ω’-Alkenyloxy)-substituted 5,6-dihydro-1H-pyridin-2-ones II (n = 1, 2) were accessible in 43 and 37% overall yield from 3-diazopiperidin-2-one by an α,α-chloroselenylation reaction at the 3-position followed by nucleophilic displacement of a chloride ion with an ω-alkenolate and oxidative elimination of selenoxide. Upon irradiation at λ = 254 nm, the precursor compounds underwent a clean intramol. [2+2] photocycloaddition reaction. The substrates tethered by a two-atom chain exclusively delivered the resp. crossed products III (X = CH2, O), and the substrates tethered by longer chains, gave the straight products IV (n = 1, X = CH2, O; n = 2, X = CH2). The completely regio- and diastereoselective photocycloaddition reactions proceeded in 63-83% yield. Irradiation in the presence of the chiral templates (-)-V and (+)-VI at -75° in toluene rendered the reactions enantioselective with selectivities varying between 40 and 85% ee. Truncated template rac-VI was prepared as a noranalogue of the well-established template V in eight steps and 56% yield from the Kemp triacid. Subsequent resolution delivered the enantiomerically pure templates (-)-ent-VI and (+)-VI. The outcome of the reactions is compared to the results achieved with 4-substituted 5,6-dihydro-1H-pyridin-2-ones and quinolones. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).Electric Literature of 14602-86-9

The Article related to alkenyl substituted valerolactam selenylation elimination, dihydropyridinone alkenyl substituted derivative preparation photocycloaddition, piperidinone tricyclic derivative stereoselective preparation chiral complexing reagent, kemp triacid tetrahydroaminonaphthol chiral template preparation resolution and other aspects.Electric Literature of 14602-86-9

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On December 31, 2019, He, Zhi-Tao; Hartwig, John F. published an article.Related Products of 98946-18-0 The title of the article was Palladium-catalyzed α-arylation for the addition of small rings to aromatic compounds. And the article contained the following:

A generally applicable approach to attach small rings to a wide range of aromatic compounds by palladium-catalyzed α-arylation of cyclopropyl, cyclobutyl and azetidinyl esters was reported. The direct α-arylation of cyclopropyl esters and cyclobutyl esters was achieved in high yield by ensuring that rate of coupling exceeded rate of Claisen condensation. The α-arylation of azetidines was achieved without ring opening of strained saturated heterocycle by conducting reactions with an azetidine derivative bearing a benzyl protecting group on nitrogen. Mechanistic studies showed that α-arylation of small rings was challenging because of the weak acidity of α C-H bond (cyclopropanes), strong sensitivity of strained esters to Claisen condensation (cyclobutatanes), or facile decomposition of enolates (azetidinyl esters). The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Related Products of 98946-18-0

The Article related to aryl cyclobutyl ester preparation, cyclobutyl ester aryl bromide alpha arylation palladium catalyst, azetidinyl ester aryl preparation, azetidine ester aryl bromide alpha arylation palladium catalyst, cyclopropyl ester aryl preparation, bromoarene cyclopropyl ester alpha arylation palladium catalyst and other aspects.Related Products of 98946-18-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On October 29, 1992, Shibayama, Katsuhiro; Makino, Tetsuya; Imaoka, Takayuki; Katou, Tetsuya; Kaneko, Masayuki published a patent.Formula: C7H6ClNO2 The title of the patent was Preparation of tricyclic triazole derivatives as antiinflammatory, antiallergic, and anti-platelet activating factor (PAF) drugs. And the patent contained the following:

The title compounds [I; R1 = H, alkyl, C3-5 cycloalkyl; R2, R3 = H, alkyl, alkoxy, halo; W = CO, CR4R5; R4, R5 = H, alkyl; A = C1-5 linear or branched (un)saturated alkylene optionally containing heteroatoms; l = 0-2; n = 1-3; Y = N, C; Z = C(B)Ar1Ar2, CAr1Ar2, OCHAr1Ar2, fused aromatic ring; B = H, HO, MeO; Ar1, Ar2 = H, (un)substituted aryl] are prepared Thus, cyclocondensation of 4-(3-ethoxypropyl)-2-chloroquinoxaline (preparation given) with acetohydrazide in BuOH under reflux and bromination of the the resulting [1,2,4]triazolo[4,3-a]quinoxaline derivative (II; R6 = OEt) with 48% HBr followed by condensation with 4-(diphenylmethylene)piperidine and NaCO3 in DMF at 60-70° gave a title compound (II; R6 = Q). I at 50 mg/kg p.o. inhibited 44-75% passive cutaneous anaphylaxis and 19-87% histamine-induced allergy in rats. I showed IC50 of 0.013-5.4 μg/mL for inhibiting PAF-induced rabbit’s blood platelet aggregation. A tablet formulation containing II (R6 = Q1) was given. A total of 121 I were prepared The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Formula: C7H6ClNO2

The Article related to tricyclic triazole preparation antiinflammatory, antiallergic triazoloquinoxaline triazolobenzodiazepine, platelet activating factor antagonist triazoloquinoxaline, paf antagonist triazoloquinoxaline, blood platelet aggregation inhibitor triazoloquinoxaline, triazolobenzimidazole antiinflammatory and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On January 17, 2020, Chen, Kai-Chi; Barve, Indrajeet J.; Sun, Chung-Ming published an article.Formula: C7H6ClNO2 The title of the article was Catalyst-Controlled Regioselective Synthesis of Benzotriazolodiazepin-7-ones and Benzotriazolodiazocin-8-ones. And the article contained the following:

A catalyst-controlled highly chemoselective and regioselective intramol. cycloamidation of triazol-1-ylbenzamides toward the synthesis of scarcely known heterocycles is reported. In the presence of a palladium catalyst, this cycloisomerization reaction afforded substituted benzotriazolodiazepin-7-ones via intramol. insertion of a palladium into C-C triple bond in a 7-exo-dig way. Alternatively, the use of a silver catalyst in the reaction produced substituted benzotriazolodiazocin-8-ones in a highly regioselective manner through 8-endo-dig intramol. ring closure. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Formula: C7H6ClNO2

The Article related to palladium catalyst triazolylbenzamide diastereoselective chemoselective regioselective intramol cycloamidation, benzotriazolodiazepinone preparation, silver catalyst triazolylbenzamide diastereoselective chemoselective regioselective intramol cycloamidation, benzotriazolodiazocinone preparation and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On June 3, 2020, Song, Bichao; Xie, Peipei; Li, Yingzi; Hao, Jiping; Wang, Lu; Chen, Xiangyang; Xu, Zhongliang; Quan, Haitian; Lou, Liguang; Xia, Yuanzhi; Houk, K. N.; Yang, Weibo published an article.COA of Formula: C7H6ClNO2 The title of the article was Pd-Catalyzed Decarboxylative Olefination: Stereoselective Synthesis of Polysubstituted Butadienes and Macrocyclic P-glycoprotein Inhibitors. And the article contained the following:

The efficient and stereoselective synthesis of polysubstituted butadienes, especially the multifunctional butadienes, represents a great challenge in organic synthesis. Herein, we wish to report a distinctive Pd(0) carbene-initiated decarboxylative olefination approach that enables the direct coupling of diazo esters with vinylethylene carbonates (VECs), vinyl oxazolidinones, or vinyl benzoxazinones to afford alc.-, amine-, or aniline-containing 1,3-dienes in moderate to high yields and with excellent stereoselectivity. This protocol features operational simplicity, mild reaction conditions, a broad substrate scope, and gram-scalability. Notably, a structurally unique allylic Pd(II) intermediate was isolated and characterized. DFT calculation and control experiments demonstrated that a rare Pd(0) carbene intermediate could be involved in this reaction. Moreover, the polysubstituted butadienes as novel building blocks were unprecedentedly assembled into macrocycles, which efficiently inhibited the P-glycoprotein and dramatically reversed multidrug resistance in cancer cells by 190-fold. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).COA of Formula: C7H6ClNO2

The Article related to vinylethylene carbonate diazo ester palladium decarboxylative olefination catalyst, vinyloxazolidinone diazo ester palladium decarboxylative olefination catalyst, vinylbenzoxazinone diazo ester palladium decarboxylative olefination catalyst, butadiene polysubstituted stereoselective preparation and other aspects.COA of Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On November 28, 2020, Hawkins, Paige M. E.; Tran, Wendy; Nagalingam, Gayathri; Cheung, Chen-Yi; Giltrap, Andrew M.; Cook, Gregory M.; Britton, Warwick J.; Payne, Richard J. published an article.Recommanded Product: tert-Butyl trichloroacetimidate The title of the article was Total synthesis and antimycobacterial activity of Ohmyungsamycin A, Deoxyecumicin, and Ecumicin. And the article contained the following:

The ohmyungsamycin and ecumicin natural product families are structurally related cyclic depsipeptides that display potent antimycobacterial activity. Herein the total syntheses of ohmyungsamycin A, deoxyecumicin, and ecumicin are reported, together with the direct biol. comparison of members of these natural product families against Mycobacterium tuberculosis (Mtb), the etiol. agent of tuberculosis (TB). The synthesis of each of the natural products employed a solid-phase strategy to assemble the linear peptide precursor, involving a key on-resin esterification and an optional on-resin dimethylation step, before a final solution-phase macrolactamization between the non-proteinogenic N-methyl-4-methoxy-L-tryptophan amino acid and a bulky N-methyl-L-valine residue. The synthetic natural products possessed potent antimycobacterial activity against Mtb with MIC90’s ranging from 110-360 nM and retained activity against Mtb in Mtb-infected macrophages. Deoxyecumicin also exhibited rapid bactericidal killing against Mtb, sterilizing cultures after 21 days. The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).Recommanded Product: tert-Butyl trichloroacetimidate

The Article related to natural product cyclic peptide ohmyungsamycin deoxyecumicin ecumicin total synthesis, cyclopeptide antimycobacterial agent tuberculostatic drug, deoxyecumicin sterilizing agent mycobacterium tuberculosis, solid phase peptide synthesis esterification dimethylation macrolactamization, natural products, peptides, solid-phase synthesis, total synthesis, tuberculosis and other aspects.Recommanded Product: tert-Butyl trichloroacetimidate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On June 30, 2022, Watanabe, Akio; Hirooka, Yasuo; Tsuboi, Kazuma published a patent.SDS of cas: 59833-69-1 The title of the patent was Preparation of N-phenyl-1H-pyrazolecarboxamides, N-phenyl-1H-pyrrolecarboxamides, and N-phenylbenzamides as prostanoid receptor EP2 antagonists. And the patent contained the following:

The title anilides represented by formula I [R1 = CO2 R101, SO3H, SO2NHR102, CONHSO2R103, SO2NHCOR104, CONR105R106, tetrazolyl, or cyano; R101-R106 = each independently H, C1-4 alkyl, C1-4 alkoxy, C1-4 halo alkyl, or dimethylamino; R8, R9 = each independently H, halo, C1-4 alkyl, or HO; when R8 = R9 = C1-4 alkyl, R8 and R9 are bonded to the adjacent benzene ring at o-position to form a C3-7 carbocyclic ring; R2 = H or C1-4 alkyl; R3 = halo, HO, cyano, or each (un)substituted C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, 3-6 membered ring group,NH2, or SH, etc.; R4 = halo or each (un)substituted C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, 3-6 membered ring group, O-(3-6 membered ring group), C1-4 alkylene-(3-5 membered ring group); R5 = CF3 or each (un)substituted C3-10 carbocyclyl or 3-10 membered heterocyclyl; Y = a bond, O, or optionally oxidized S; L = each (un)substituted C1-8 alkylene, C2-8 alkenylene, or C2-8 alkynylene each optionally having the CH2 group replaced with O, S, S(O), or SO2; ring 1 = nitrogen-containing mono- or bicyclic ring; n = 1, 2, 3, or 4; m = 0, 1, 2, or 3] or pharmaceutically acceptable salts thereof are prepared The compounds I have an antagonistic activity against EP2 receptor, good solubility, and high stability against human liver microsome and provide medicines for the prevention and/or treatment of a disease caused by activation of an EP2 receptor. The disease includes endometriosis, uterine myoma, menorrhagia, adenomyosis, dysmenorrhea, chronic pelvic pain syndrome, cancer, inflammatory pain, neuropathic pain, headache, migraine, postoperative pain, interstitial cystitis, leiomyoma, irritable colon syndrome, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, rheumatism, osteoarthritis, gout, allergic disease, hypertension, brain damage, ischemia , Stroke, renal disease, transplant rejection, atherosclerosis, ischemic heart disease, acne vulgaris, asthma, prostatitis, glomerulonephritis, sarcoidosis, vasculitis, or autoimmune disease. More specifically the cancer is breast cancer, ovarian cancer, colon cancer, lung cancer, prostate cancer, head and neck cancer, lymphoma, uveal melanoma, thymoma, mesoderma, esophageal cancer, gastric cancer, duodenal cancer, hepatocellular carcinoma, bile duct cancer, gallbladder cancer cancer, pancreatic cancer, renal cell carcinoma , renal and urinary tract cancer, bladder cancer, penis cancer, testis cancer, uterine cancer, vaginal cancer, genital cancer, skin cancer (For example, malignant melanoma), malignant bone tumor, Soft tissue sarcoma, chondrosarcoma, leukemia, myelodysplastic syndrome, brain tumor or multiple myeloma. Thus, etherification of Me 2-[3-[[[1-(sec-butyl)-5-[2-[(2-fluoropyridin-4-yl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetate with 2-fluoro-4-hydroxypyridine using cyanomethylenetributylphosphorane in toluene at 90° for 2.5 h gave Me 2-[3-[[[1-(sec-butyl)-5-[2-[(2-fluoropyridin-4-yl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetate which underwent alkali hydrolysis in a mixture of 5 N aqueous NaOH solution and methanol at room temperature for 30 min followed by acidification with 2 N aqueous HCl solution to give [3-[[[1-sec-Butyl-5-[2-[(2-fluoro-4-pyridinyl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetic acid (II). II and [3-[[[1-((2S)-2-butyl)-5-[2-[(2-chloro-6-fluoro-4-pyridinyl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetic acid (III) inhibited the PGE2-induced production of cAMP in CHO cells expressing human EP2 receptor with IC50 of 2.5 and 0.3 nM, resp., and exhibited a selective EP2 selectivity over production DP receptor with a DP/EP2 receptor inhibition selectivity ratio of 2,565 and 3,681, resp. A tablet formulation containing II was described. The experimental process involved the reaction of Methyl 2-(3-amino-4-chlorophenyl)acetate(cas: 59833-69-1).SDS of cas: 59833-69-1

The Article related to anilide preparation prostanoid receptor ep2 selective antagonist, anticancer phenylpyrazolecarboxamide phenylpyrrolecarboxamide phenylbenzamide preparation, cancer endometriosis uterine myoma menorrhagia adenomyosis dysmenorrhea treatment, phenylpyrazolecarboxamide phenylpyrrolecarboxamide phenylbenzamide preparation prostanoid receptor ep2 selective antagonist and other aspects.SDS of cas: 59833-69-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On September 16, 2016, Zhang, Ziqian; Li, Yi; He, Haihong; Qian, Xuhong; Yang, Youjun published an article.SDS of cas: 99-60-5 The title of the article was Mild Chemotriggered Generation of a Fluorophore-Tethered Diazoalkane Species via Smiles Rearrangement. And the article contained the following:

Nitrosamino naphthalenedicarboximide I and a related disulfide underwent Smiles rearrangement in the presence of nucleophiles to generate diazo compounds in situ under mild conditions (in aqueous buffer or MeCN at ambient temperature); reaction with nucleophiles such as carboxylic acids RCO2H [R = Me, i-Pr, Me(CH2)10, (E,E)-MeCH:CHCH:CH, Me2C:CH, 1-adamantyl, Ph, 3-HOC6H4, 2-HOC6H4, 2-Ph2PC6H4, 4-MeC6H4, 4-BrC6H4, 4-O2NC6H4, 2-Cl-4-O2NC6H3, 4-Et2NC6H4, 1-naphthyl] or dimethylamine or activation with glutathione yielded fluorescent products such as acyloxyethylthio naphthalenedicarboximides II [R = Me, i-Pr, Me(CH2)10, (E,E)-MeCH:CHCH:CH, Me2C:CH, 1-adamantyl, Ph, 3-HOC6H4, 2-HOC6H4, 2-Ph2PC6H4, 4-MeC6H4, 4-BrC6H4, 4-O2NC6H4, 2-Cl-4-O2NC6H3, 4-Et2NC6H4, 1-naphthyl] in 16-45% yields. The structure of I was determined by X-ray crystallog. The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).SDS of cas: 99-60-5

The Article related to nitrosamino naphthalenedicarboximide preparation rearrangement nucleophile, acyloxyethylthio naphthalenedicarboximide preparation fluorescence, diazo compound formation smiles rearrangement nitrosamino naphthalenedicarboximide, carboxylic acid reaction in situ generated diazo compound, acetylthioethyl nitrosamino naphthalenedicarboximide mol crystal structure and other aspects.SDS of cas: 99-60-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On February 1, 2021, Kadaiahgari, Chandra Sekhar; Saha, Moumita; Ravuri, Srinath; Nandigama, Sandeep; Saha, Krishna Das; Banerji, Biswadip published an article.Formula: C7H6ClNO2 The title of the article was Sulphonamide-Containing Oxazoline Hybrids as New Class of Neuroprotective Agents and Lead Molecule as Autophagy Inducer. And the article contained the following:

In the present study, a series of sulfonamide containing oxazoline hybrids I [R1 = 2-NH2, 3-NH2, 4-NH2; R2 = H, Cl, MeO; R3 = H, MeO; R2R3 = HC=CHCH=CH] were synthesized and their neuroprotective efficacy in neuronal cell lines was explored. All the compounds I showed moderate to good neuroprotection against adrenal medulla cell lines (PC 12). Compound I [R1 = 4-NH2; R2R3 = HC=CHCH=CH] had good neuroprotective activity against PC 12 cell lines showing increased expression of autophagy regulatory proteins (ATG7, LC 3B, p62, Beclin-1) and anti-apoptotic proteins (Bcl-2) and also decreased expression of pro-apoptotic proteins (Bax and Bad). This study demonstrated clearly that compound I [R1 = 4-NH2; R2R3 = HC=CHCH=CH] showed neuroprotective effect through the induction of autophagy and opens up new avenues for a new class of compounds as neuroprotective therapeutic agents. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Formula: C7H6ClNO2

The Article related to amino dihydrooxazolyl aryl benzenesulfonamide preparation neuroprotective agent autophagy human, aminophenyl sulfonylamino hydroxyethyl aryl carboxamide preparation mitsunobu reaction, hydroxyethyl nitrophenyl sulfonylamino aryl carboxamide preparation reduction catalyst iron, nitrophenyl sulfonylamino aryl carboxylic acid preparation aminoethanol coupling and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On April 16, 2021, Xu, Changming; Qi, Yinsheng; Yang, Xinshuang; Li, Xiangfan; Li, Zhenpeng; Bai, Lei published an article.HPLC of Formula: 14602-86-9 The title of the article was Development of C2-Symmetric Chiral Spirocyclic Phase-Transfer Catalysts: Synthesis and Application to Asymmetric Alkylation of Glycinate Schiff Base. And the article contained the following:

A class of C2-sym. chiral spirocyclic phase-transfer catalysts based on the tetramethyl-1,1′-spirobiindane scaffold such as I·Br- was synthesized from com. available bisphenol A in 12 steps in 22-25% total yields; the scaffold features a more rigid and stable backbone and smaller dihedral angles and can be easily modified. These catalysts show high catalytic performance in the asym. alkylation of tert-Bu glycinate Schiff base Ph2C:NCH2CO2t-Bu at only 2 mol % catalyst loading, giving nonracemic protected α-amino acid esters such as (R)-Ph2C:NCH(CH2Ph)CO2t-Bu in up to 92% yield and 98% ee. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).HPLC of Formula: 14602-86-9

The Article related to spirobiindanoazocinium nonracemic preparation catalyst enantioselective phase transfer alkylation, diphenylmethyleneamino ester enantioselective preparation, nonracemic spirobiindanoazocinium bromide enantioselective phase transfer alkylation catalyst, alkyl bromide enantioselective alkylation diphenylmethyleneamino ester spirobiindanoazocinium catalyst and other aspects.HPLC of Formula: 14602-86-9

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics